Single administration of intracameral bimatoprost implant: IOP lowering, safety

Conference|AAO

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

See more AAO coverage here

Related Videos
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
What are you most excited about in the field of retina? Tunde Peto, MD, PhD weighs in
Leveraging noninvasive ophthalmic imaging for patients with Alzheimer disease and analyzing UK Biobank data
EURETINA 2022: Leadership discusses what to expect, outlines Women in Retina program
Related Content

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

UF Health researchers’ gene therapy for retina disorder shows promise in early testing

March 14th 2023

What to expect from virtual AAO 2020

November 5th 2020

APAO 2023: Testing a treatment theory for children with keratoconus

February 25th 2023

APAO 2023: Diffuse atrophy in children: Key to development of pathologic myopia in adults

February 24th 2023

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

UF Health researchers’ gene therapy for retina disorder shows promise in early testing

March 14th 2023

What to expect from virtual AAO 2020

November 5th 2020

APAO 2023: Testing a treatment theory for children with keratoconus

February 25th 2023

APAO 2023: Diffuse atrophy in children: Key to development of pathologic myopia in adults

February 24th 2023

Study: Cones in retinal degeneration, believed to be dormant, may retain visual function

March 28th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

UF Health researchers’ gene therapy for retina disorder shows promise in early testing

March 14th 2023

What to expect from virtual AAO 2020

November 5th 2020

APAO 2023: Testing a treatment theory for children with keratoconus

February 25th 2023

APAO 2023: Diffuse atrophy in children: Key to development of pathologic myopia in adults

February 24th 2023
© 2023 MJH Life Sciences

All rights reserved.